We are live on
!
Find out more
BlackRock Advisors Portfolio holdings
AUM
$98.8B
Turnover
6.58%
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
+1.93%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.33%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.6B
AUM Growth
-$1.7B
(-1.7%)
Cap. Flow
-$2.11B
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
3,772
New
78
Increased
2,174
Reduced
812
Closed
154
Avg Time Held Equity + Options
1.6
years
Top 10 Avg Time Held Equity + Options
0.8
years
Top 20 Avg Time Held Equity + Options
1
year
Avg Time Held Equity only
1.6
years
Top 10 Avg Time Held Equity only
0.9
years
Top 20 Avg Time Held Equity only
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$461M |
| 2 |
Elevance Health
ELV
|
+$290M |
| 3 |
Anadarko Petroleum
APC
|
+$241M |
| 4 |
Mobileye N.V.
MBLY
|
+$234M |
| 5 |
Microsoft
MSFT
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$382M |
| 2 |
HSP
HOSPIRA INC
HSP
|
+$235M |
| 3 |
Merck
MRK
|
+$227M |
| 4 |
AGN
Allergan Inc
AGN
|
+$199M |
| 5 |
American Express
AXP
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.77% |
| 2 | Financials | 17.01% |
| 3 | Industrials | 9.86% |
| 4 | Miscellaneous | 9.44% |
| 5 | Technology | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
SPDR Gold Trust
GLD
$141B
| $341M | 0.35% |
3,000,322
-337,315
| -10% | -$39.5M |
2013 Q2
7 quarters
|
|
77
CVS Health
CVS
$118B
| $336M | 0.34% |
3,260,044
-40,479
| -1% | -$4.1M |
2013 Q2
7 quarters
|
|
78
CME Group
CME
$106B
| $323M | 0.33% |
3,415,165
+460,709
| +16% | +$42.7M |
2013 Q2
7 quarters
|
|
79
SLB Ltd
SLB
$73.5B
| $321M | 0.33% |
3,852,675
-144,544
| -4% | -$12M |
2013 Q2
7 quarters
|
|
80
Abbott
ABT
$181B
| $319M | 0.33% |
6,879,358
+1,036,376
| +18% | +$47.6M |
2013 Q2
7 quarters
|
|
81
Perrigo
PRGO
$2.31B
| $317M | 0.32% |
1,913,593
-29,040
| -1% | -$4.63M |
2014 Q1
4 quarters
|
|
82
American Water Works
AWK
$26.8B
| $313M | 0.32% |
5,765,450
-270,950
| -4% | -$14.7M |
2013 Q2
7 quarters
|
|
83
Biogen
BIIB
$34.4B
| $306M | 0.31% |
725,128
-55,059
| -7% | -$21.7M |
2013 Q2
7 quarters
|
|
84
Becton Dickinson
BDX
$52.2B
| $297M | 0.3% |
2,116,989
+156,198
| +8% | +$21.9M |
2013 Q2
7 quarters
|
|
85
Freeport-McMoran
FCX
$99.9B
| $293M | 0.3% |
15,459,939
+1,567,035
| +11% | +$31M |
2013 Q2
7 quarters
|
|
86
Humana
HUM
$49.6B
| $292M | 0.3% |
1,639,962
+378,489
| +30% | +$59.9M |
2013 Q2
7 quarters
|
|
87
United Therapeutics
UTHR
$22.9B
| $284M | 0.29% |
1,646,412
-33,505
| -2% | -$5.11M |
2013 Q2
7 quarters
|
|
|
CELG
88
DELISTED
Celgene Corp
CELG
| $284M | 0.29% |
2,459,791
-323,174
| -12% | -$38.6M |
2013 Q2
7 quarters
|
|
89
Berkshire Hathaway Class B
BRK.B
$1.14T
| $280M | 0.29% |
1,940,758
+37,169
| +2% | +$5.47M |
2013 Q2
7 quarters
|
|
90
iShares Gold Trust
IAU
$61.8B
| $279M | 0.29% |
12,199,525
-2,653,658
| -18% | -$62.6M |
2013 Q2
7 quarters
|
|
91
Sempra
SRE
$54.5B
| $277M | 0.28% |
5,084,020
-103,730
| -2% | -$5.72M |
2013 Q2
7 quarters
|
|
92
Altria Group
MO
$125B
| $274M | 0.28% |
5,482,647
-273,216
| -5% | -$14.5M |
2013 Q2
7 quarters
|
|
93
DuPont de Nemours
DD
$17.6B
| $272M | 0.28% |
2,237,931
+13,569
| +0.6% | +$1.61M |
2013 Q2
7 quarters
|
|
94
Liberty Global Class A
LBTYA
$2.66B
| $271M | 0.28% |
6,389,647
-648,665
| -9% | -$27.1M |
2013 Q4
5 quarters
|
|
95
Bausch Health
BHC
$2.36B
| $271M | 0.28% |
1,365,358
-574,661
| -30% | -$102M |
2013 Q2
7 quarters
|
|
96
Thermo Fisher Scientific
TMO
$255B
| $271M | 0.28% |
2,014,019
+54,377
| +3% | +$7.01M |
2013 Q2
7 quarters
|
|
|
97
CALL
SPDR Gold Trust
GLD
$141B
| $266M | 0.27% |
2,338,100
-485,800
| -17% | -$56.8M |
2014 Q1
4 quarters
|
|
98
Cigna
CI
$79.9B
| $261M | 0.27% |
2,016,530
+351,057
| +21% | +$40.8M |
2013 Q2
7 quarters
|
|
99
Rockwell Automation
ROK
$47.3B
| $254M | 0.26% |
2,193,529
-251,045
| -10% | -$28.2M |
2013 Q2
7 quarters
|
|
100
Bread Financial
BFH
$3.94B
| $253M | 0.26% |
1,070,146
-45,506
| -4% | -$10.4M |
2013 Q2
7 quarters
|
|
Similar funds
CIM
KAM
WC
BlackRock Advisors's Q1 2015 Portfolio in Review
As of Q1 2015, BlackRock Advisors held 3,772 positions worth $97.6B, down 1.7% from $99.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock Advisors's Q1 2015 filing shows 78 new, 2,174 increased, 812 reduced and 154 closed positions. Its largest new stake was Mobileye N.V.: 6,000,666 shares worth $252M. The largest sale was Chevron, an estimated $382M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Financials and Industrials.
- BlackRock Advisors's largest Q1 2015 buy was Mobileye N.V.: 6,000,666 shares worth $252M.
- BlackRock Advisors added most to UnitedHealth in Q1 2015, an estimated $461M increase.
- BlackRock Advisors's biggest Q1 2015 reduction was Chevron, cutting an estimated $382M.
- BlackRock Advisors fully exited Allergan Inc in Q1 2015, selling an estimated $199M.
- BlackRock Advisors's ten largest holdings make up 14% of its $97.6B portfolio in Q1 2015.
- BlackRock Advisors opened 78 new positions and closed 154 in Q1 2015.
- BlackRock Advisors's portfolio value fell 1.7% quarter-over-quarter to $97.6B.
Based on BlackRock Advisors's 13F filing for Q1 2015, filed 13 May 2015.